Lyell Immunopharma | EFFECT:其他
18:18
Lyell Immunopharma | ARS:年度报告
04/23 04:22
Lyell Immunopharma | DEFA14A:其他
04/23 04:22
Lyell Immunopharma | DEF 14A:股东委托书决议
04/23 04:17
Lyell Immunopharma | S-3:特定交易注册声明
03/01 02:35
Lyell Immunopharma | S-8:员工福利计划证券登记
03/01 02:35
Lyell Immunopharma | 10-K:年度报表
02/29 11:28
Lyell Immunopharma | 8-K:Lyell Immunopharma报告了2023年第四季度和全年业务亮点和财务业绩
02/29 05:15
Lyell Immunopharma | SC 13G/A:超过5%持股股东披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等
02/15 04:24
Lyell Immunopharma | 4:持股变动声明-高管 Lang Matthew
02/14 09:31
Lyell Immunopharma | 4:持股变动声明-高管 Hill Stephen J.
02/14 09:26
Lyell Immunopharma | 4:持股变动声明-高管 Lee Gary K.
02/14 09:26
Lyell Immunopharma | 4:持股变动声明-高管 Newton Charles W.
02/14 09:21
Lyell Immunopharma | 4:持股变动声明-高管 Seely Lynn
02/14 09:21
Lyell Immunopharma | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.40%)
02/14 06:52
Lyell Immunopharma | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.7%)
01/30 06:37
Lyell Immunopharma | 4:持股变动声明-首席财务官 Newton Charles W.
2023/11/21 09:55
Lyell Immunopharma | 4:持股变动声明-高管 Lee Gary K.
2023/11/21 09:54
Lyell Immunopharma | 4:持股变动声明-高管 Seely Lynn
2023/11/21 09:53
Lyell Immunopharma | 4:持股变动声明-高管 Hill Stephen J.
2023/11/21 09:52
暂无数据
暂无数据